Celina G. Kleer

23.5k total citations · 4 hit papers
174 papers, 17.2k citations indexed

About

Celina G. Kleer is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Celina G. Kleer has authored 174 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 72 papers in Cancer Research and 65 papers in Oncology. Recurrent topics in Celina G. Kleer's work include Breast Cancer Treatment Studies (43 papers), Breast Lesions and Carcinomas (38 papers) and Cancer Cells and Metastasis (34 papers). Celina G. Kleer is often cited by papers focused on Breast Cancer Treatment Studies (43 papers), Breast Lesions and Carcinomas (38 papers) and Cancer Cells and Metastasis (34 papers). Celina G. Kleer collaborates with scholars based in United States, Ghana and France. Celina G. Kleer's co-authors include Sofía D. Merajver, Max S. Wicha, Michael S. Sabel, Christophe Ginestier, Suling Liu, Gabriela Dontu, Mark A. Rubin, Emmanuelle Charafe‐Jauffret, Anne F. Schott and Julie Dutcher and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Celina G. Kleer

170 papers receiving 16.9k citations

Hit Papers

ALDH1 Is a Marker of Norm... 2003 2026 2010 2018 2007 2003 2013 2011 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
    2007 3.1k citations Christophe Ginestier, Emmanuelle Charafe‐Jauffret et al. profile →
  2. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
    2003 1.3k citations Celina G. Kleer, Sooryanarayana Varambally et al. Proceedings of the National Academy of Sciences profile →
  3. Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity
    2013 672 citations Celina G. Kleer et al. profile →
  4. Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
    2011 495 citations Suling Liu, Christophe Ginestier et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Celina G. Kleer United States 65 9.2k 7.9k 5.8k 2.0k 1.9k 174 17.2k
Bryan T. Hennessy Ireland 59 9.7k 1.1× 9.0k 1.1× 6.4k 1.1× 3.1k 1.5× 3.0k 1.6× 266 19.8k
Ann D. Thor United States 68 8.3k 0.9× 9.7k 1.2× 5.8k 1.0× 2.4k 1.2× 2.4k 1.3× 209 18.3k
Britta Weigelt United States 70 7.8k 0.8× 8.1k 1.0× 8.4k 1.5× 3.5k 1.7× 3.0k 1.6× 311 19.1k
Fernando Schmitt Portugal 60 5.5k 0.6× 5.3k 0.7× 4.4k 0.8× 2.1k 1.1× 2.7k 1.4× 315 13.0k
François Bertucci France 72 7.5k 0.8× 8.9k 1.1× 5.4k 0.9× 1.9k 0.9× 4.8k 2.6× 515 18.8k
Xavier Matías‐Guiu Spain 64 6.4k 0.7× 4.2k 0.5× 3.5k 0.6× 2.4k 1.2× 1.8k 1.0× 435 16.1k
Melinda E. Sanders United States 45 6.0k 0.7× 6.5k 0.8× 4.8k 0.8× 1.2k 0.6× 2.5k 1.4× 119 13.3k
Stan B. Kaye United Kingdom 65 8.7k 0.9× 9.5k 1.2× 3.6k 0.6× 1.6k 0.8× 4.2k 2.2× 217 19.2k
Dennis C. Sgroi United States 71 11.1k 1.2× 8.7k 1.1× 6.8k 1.2× 1.8k 0.9× 2.8k 1.5× 173 21.0k
John M.S. Bartlett United Kingdom 60 6.2k 0.7× 10.5k 1.3× 7.0k 1.2× 1.9k 1.0× 3.7k 2.0× 310 18.8k

Countries citing papers authored by Celina G. Kleer

Since Specialization
Citations

This map shows the geographic impact of Celina G. Kleer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celina G. Kleer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celina G. Kleer more than expected).

Fields of papers citing papers by Celina G. Kleer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celina G. Kleer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celina G. Kleer. The network helps show where Celina G. Kleer may publish in the future.

Co-authorship network of co-authors of Celina G. Kleer

This figure shows the co-authorship network connecting the top 25 collaborators of Celina G. Kleer. A scholar is included among the top collaborators of Celina G. Kleer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celina G. Kleer. Celina G. Kleer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Janggun, Sebastiano Andò, Roberta Caruso, et al.. (2023). Personalized Oncology by In Vivo Chemical Imaging: Photoacoustic Mapping of Tumor Oxygen Predicts Radiotherapy Efficacy. ACS Nano. 17(5). 4396–4403. 12 indexed citations
2.
Li, Wei, Takashi Tanikawa, Ilona Kryczek, et al.. (2018). Aerobic Glycolysis Controls Myeloid-Derived Suppressor Cells and Tumor Immunity via a Specific CEBPB Isoform in Triple-Negative Breast Cancer. Cell Metabolism. 28(1). 87–103.e6. 326 indexed citations
3.
Cani, Andi K., Daniel H. Hovelson, Andrew S. McDaniel, et al.. (2015). Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes Tumors. Molecular Cancer Research. 13(4). 613–619. 97 indexed citations
4.
Pal, Anupama, Wei Huang, Xin Li, et al.. (2012). CCN6 Modulates BMP Signaling via the Smad-Independent TAK1/p38 Pathway, Acting to Suppress Metastasis of Breast Cancer. Cancer Research. 72(18). 4818–4828. 62 indexed citations
5.
Pang, Judy, Kathy A. Toy, Baffour Awuah, et al.. (2012). Invasive breast carcinomas in Ghana: high frequency of high grade, basal-like histology and high EZH2 expression. Breast Cancer Research and Treatment. 135(1). 59–66. 43 indexed citations
6.
Dresser, Karen, et al.. (2011). Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancer. Breast Cancer Research and Treatment. 130(3). 759–772. 10 indexed citations
7.
Liu, Suling, Christophe Ginestier, Sing J. Ou, et al.. (2011). Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks. Cancer Research. 71(2). 614–624. 495 indexed citations breakdown →
8.
Rosenthal, Devin T., Silvia Escudero, Liwei Bao, et al.. (2011). p38γ Promotes Breast Cancer Cell Motility and Metastasis through Regulation of RhoC GTPase, Cytoskeletal Architecture, and a Novel Leading Edge Behavior. Cancer Research. 71(20). 6338–6349. 49 indexed citations
9.
González, Maria E., et al.. (2011). Histone Methyltransferase EZH2 Induces Akt-Dependent Genomic Instability and BRCA1 Inhibition in Breast Cancer. Cancer Research. 71(6). 2360–2370. 89 indexed citations
10.
Huang, Wei, Maria E. González, Kathy A. Toy, Mousumi Banerjee, & Celina G. Kleer. (2010). Blockade of CCN6 (WISP3) Activates Growth Factor–Independent Survival and Resistance to Anoikis in Human Mammary Epithelial Cells. Cancer Research. 70(8). 3340–3350. 29 indexed citations
11.
Hayes, Michael, et al.. (2008). Genetic Changes of Wnt Pathway Genes Are Common Events in Metaplastic Carcinomas of the Breast. Clinical Cancer Research. 14(13). 4038–4044. 133 indexed citations
12.
Liu, Suling, Christophe Ginestier, Emmanuelle Charafe‐Jauffret, et al.. (2008). BRCA1 regulates human mammary stem/progenitor cell fate. Proceedings of the National Academy of Sciences. 105(5). 1680–1685. 336 indexed citations
13.
Kleer, Celina G., Noga Bloushtain-Qimron, Yu‐Hui Chen, et al.. (2008). Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Clinical Cancer Research. 14(17). 5357–5367. 80 indexed citations
14.
Kunju, Lakshmi P., Ying Ding, & Celina G. Kleer. (2008). Tubular carcinoma and grade 1 (well‐differentiated) invasive ductal carcinoma: Comparison of flat epithelial atypia and other intra‐epithelial lesions. Pathology International. 58(10). 620–625. 8 indexed citations
15.
Huang, Wei, Yanhong Zhang, Sooryanarayana Varambally, et al.. (2008). Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1. American Journal Of Pathology. 172(4). 893–904. 54 indexed citations
16.
Vinnedge, Lisa M. Privette, Maria E. González, Lei Ding, Celina G. Kleer, & Elizabeth M. Petty. (2007). Altered Expression of the Early Mitotic Checkpoint Protein, CHFR, in Breast Cancers: Implications for Tumor Suppression. Cancer Research. 67(13). 6064–6074. 42 indexed citations
17.
Kleer, Celina G. & Claire W. Michael. (2006). Fine-needle aspiration of breast carcinomas with prominent lymphocytic infiltrate. Deep Blue (University of Michigan). 5 indexed citations
18.
Ding, Lei, Christine A. Erdmann, Arul M. Chinnaiyan, Sofía D. Merajver, & Celina G. Kleer. (2006). Identification of EZH2 as a Molecular Marker for a Precancerous State in Morphologically Normal Breast Tissues. Cancer Research. 66(8). 4095–4099. 102 indexed citations
19.
Zeidler, Michael G. & Celina G. Kleer. (2006). The Polycomb group protein Enhancer of Zeste 2: its links to DNA repair and breast cancer. Journal of Molecular Histology. 37(5-7). 219–223. 29 indexed citations
20.
Mehra, Rohit, Sooryanarayana Varambally, Lei Ding, et al.. (2005). Identification of GATA3 as a Breast Cancer Prognostic Marker by Global Gene Expression Meta-analysis. Cancer Research. 65(24). 11259–11264. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan T. Hennessy Breakdown of academic impact, for papers by Ann D. Thor Breakdown of academic impact, for papers by Britta Weigelt Breakdown of academic impact, for papers by Fernando Schmitt Breakdown of academic impact, for papers by François Bertucci Breakdown of academic impact, for papers by Xavier Matías‐Guiu Breakdown of academic impact, for papers by Melinda E. Sanders Breakdown of academic impact, for papers by Stan B. Kaye Breakdown of academic impact, for papers by Dennis C. Sgroi Breakdown of academic impact, for papers by John M.S. Bartlett
Rankless by CCL
2026